Angewandte Chemie International Edition · 2018 · 15 citations · 22 references
PIK-75 is a phosphoinositide-3-kinase (PI3K) α-isoform-selective inhibitor with high potency. Although published structure-activity relationship data show the importance of the NO<sub>2</sub> and the Br substituents in PIK-75, none of the published studies could correctly determine the underlying reason for their importance. In this publication, we report the first X-ray crystal structure of PIK-75 in complex with the kinase GSK-3β. The structure shows an unusual U-shaped conformation of PIK-75 within the active site of GSK-3β that is likely stabilized by an atypical intramolecular Br⋅⋅⋅NO<sub>2</sub> halogen bond. NMR and MD simulations show that this conformation presumably also exists in solution and leads to a binding-competent preorganization of the PIK-75 molecule, thus explaining its high potency. We therefore suggest that the site-specific incorporation of halogen bonds could be generally used to design conformationally restricted bioactive substances with increased potencies.
22
Kinase Drug Discovery – What’s Next in the Field?
Philip Cohen, Dario R. Alessi · ACS Chemical Biology · 2012 · 384 citations · Full text
Drug Target, Immunology, S Next +17
J. A. Bertrand, Sandrine Thieffine, Anna Vulpetti et al. · Journal of Molecular Biology · 2003 · 306 citations
Structural Characterization, Non-selective Atp-mimetic Inhibitors, Biochemistry +10